Terms: = Thyroid cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Diagnosis
1457 results:
1. Diagnostic value of contrast-enhanced ultrasound in the diagnosis of papillary thyroid microcarcinoma: A systematic review and meta-analysis.
Ding Y; Peng Y; Zhang J; Pan X; Huang X; Zhang CQ
Medicine (Baltimore); 2024 Apr; 103(15):e37768. PubMed ID: 38608080
[TBL] [Abstract] [Full Text] [Related]
2. PMFFNet: A hybrid network based on feature pyramid for ovarian tumor segmentation.
Li L; He L; Guo W; Ma J; Sun G; Ma H
PLoS One; 2024; 19(4):e0299360. PubMed ID: 38557660
[TBL] [Abstract] [Full Text] [Related]
3. A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications.
Patel N; Bavikar R; Lad YP; Singh M; Dharwadkar A; Viswanathan V
J Cancer Res Ther; 2024 Jan; 20(1):311-314. PubMed ID: 38554339
[TBL] [Abstract] [Full Text] [Related]
4. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
[TBL] [Abstract] [Full Text] [Related]
5. To diagnose primary and secondary squamous cell carcinoma of the thyroid with ultrasound malignancy risk stratification.
Zhang X; Wei B; Nong L; Zhang H; Zhang J; Ye J
Front Endocrinol (Lausanne); 2023; 14():1238775. PubMed ID: 38495474
[TBL] [Abstract] [Full Text] [Related]
6. cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017.
Faramarzi S; Kiani B; Faramarzi S; Firouraghi N
BMC Cancer; 2024 Feb; 24(1):191. PubMed ID: 38342916
[TBL] [Abstract] [Full Text] [Related]
7. Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records.
Buzasi E; Carreira H; Funston G; Mansfield KE; Forbes H; Strongman H; Bhaskaran K
Lancet Healthy Longev; 2024 Mar; 5(3):e194-e203. PubMed ID: 38335985
[TBL] [Abstract] [Full Text] [Related]
8. Benign cervical schwannoma with tracheal invasion.
Lorandi LL; Ceccon FP; Callegari FM; Bacchi CE; Haddad L
Einstein (Sao Paulo); 2024; 22():eRC0528. PubMed ID: 38324847
[TBL] [Abstract] [Full Text] [Related]
9. Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
Scalia G; Silven MP; Costanzo R; Porzio M; Maugeri R; Iacopino DG; Nicoletti GF; Umana GE
Anticancer Res; 2024 Feb; 44(2):453-462. PubMed ID: 38307552
[TBL] [Abstract] [Full Text] [Related]
10. Impact of adrenal surgeon volume on outcome: analysis of 4464 operations from the United Kingdom Registry of Endocrine and thyroid Surgery (UKRETS).
Rajan S; Patel N; Stechman M; Balasubramanian SP; Mihai R; Aspinall S
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38306505
[TBL] [Abstract] [Full Text] [Related]
11. Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital.
S SY; Padma S; Sundaram PS
Ann Nucl Med; 2024 Mar; 38(3):231-237. PubMed ID: 38277114
[TBL] [Abstract] [Full Text] [Related]
12. Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features.
Tondi Resta I; Gubbiotti MA; Montone KT; Livolsi VA; Baloch ZW
Hum Pathol; 2024 Feb; 144():53-60. PubMed ID: 38244615
[TBL] [Abstract] [Full Text] [Related]
13. A neural network with a human learning paradigm for breast fibroadenoma segmentation in sonography.
Guo Y; Chen M; Yang L; Yin H; Yang H; Zhou Y
Biomed Eng Online; 2024 Jan; 23(1):5. PubMed ID: 38221632
[TBL] [Abstract] [Full Text] [Related]
14. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
[TBL] [Abstract] [Full Text] [Related]
15. Expression of
Soboska K; Kusiński M; Pawelczyk K; Migdalska-Sęk M; Brzeziańska-Lasota E; Czarnecka-Chrebelska KH
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203733
[TBL] [Abstract] [Full Text] [Related]
16. Survival Outcomes of Medullary thyroid cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract] [Full Text] [Related]
17. A mutation panel comprising BRAF
Eng ZH; Ahmad Jefry MM; Ng KL; Abdul Aziz A; Mat Junit S
Malays J Pathol; 2023 Dec; 45(3):375-390. PubMed ID: 38155379
[TBL] [Abstract] [Full Text] [Related]
18. EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers.
Gao X; Zhang R; He Y; Wang X; Bao W; Feng X; Chai J; Wang J
Ann Diagn Pathol; 2024 Apr; 69():152262. PubMed ID: 38150866
[TBL] [Abstract] [Full Text] [Related]
19. Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm.
Jia H; Qu W; Cai X; Li M; Qian Y; Jiang Z; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1286947. PubMed ID: 38075039
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.
Attia AS; Hussein S; Sameh H; Khalil A; Waley AB; Matar I; Sameh R
Cancer Biomark; 2024; 39(3):211-221. PubMed ID: 38073379
[TBL] [Abstract] [Full Text] [Related]
[Next]
